Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SVF and PRP for Knee Osteoarthritis
NCT03089762Phase 1Completed
- Sponsor
- Bioheart, Inc.
- Start
- Feb 2012
- Primary completion
- Dec 2014
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
01
Overview
Phase 1, open-label, single-arm trial of stromal vascular fraction and autologous platelet-rich plasma in osteoarthritis (OA), sponsored by Bioheart, Inc. Primary endpoint: Western Ontario and McMaster Universities Arthritis Index at 1 year. Started Feb 2012; status: completed.
02
Drugs
stromal vascular fractionautologous platelet-rich plasma
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03089762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03089762.